#VisualAbstract: Beta-Blocker Interruption Resulted in Similar Outcomes to Continuation after Myocardial Infarction
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
1. Individuals with elevated fat attenuation index scores without obstructive coronary artery disease had significantly increased rates of major adverse ...
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be ...
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
1. 30-day mortality was comparable among patients on VA-ECMO and medical therapy alone. 2. VA-ECMO was associated with increased adverse ...
1. In this randomized controlled trial, complete revascularization reduced the risk of myocardial infarction, stroke, or ischemia-driven revascularization at one ...
1. In this randomized controlled trial, complete revascularization reduced the risk of myocardial infarction, stroke, or ischemia-driven revascularization at one ...
1. In asymptomatic patients, subclinical coronary atherosclerosis was associated with an eight-fold elevated risk for myocardial infarction (MI). 2. Patients ...
1. One-quarter of top-performing quintile hospitals were reclassified to a lower performance group when Medicare Advantage beneficiaries were included compared ...
1. Bivalirudin during percutaneous coronary intervention plus high-dose infusion after demonstrated decreased all-cause mortality compared to heparin monotherapy. 2. Risk ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.